companydata.dkPHARMADIRECT A/S: Financial statements 2012
CVR: 34221138
PHARMADIRECT A/S (CVR 34221138) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -18,170 and a net result of DKK -18,170. Equity amounted to DKK 481,830. The solvency ratio was 99%.
- Gross Profit
- -18,170 kr.
- Profit/Loss
- -18,170 kr.
- Equity
- 481,830 kr.
- Total Assets
- 486,830 kr.
How creditworthy is PHARMADIRECT A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2012
As of January 25, 2012, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of PHARMADIRECT A/S.
As of January 25, 2012, Ejvind Sandal has joined the board of directors of PHARMADIRECT A/S.
As of January 25, 2012, Aksel Emanuel Bjørke has joined the board of directors of PHARMADIRECT A/S.
As of January 25, 2012, Peter Johnsen is registered as adm. dir. of PHARMADIRECT A/S.
PHARMADIRECT A/S was founded on January 25, 2012.
About PHARMADIRECT A/S
PHARMADIRECT A/S was a Danish company of the type Aktieselskab based in Køge, founded in 2012 and dissolved in 2024. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 0 employees. In 2022, the company reported a gross profit of DKK -10,000 and a net result of DKK -29,034 compared with DKK -27,431 the year before. Equity amounted to DKK 2,410,080.